by PKD Foundation Staff | Jan 16, 2020 | Awareness, Q and A, Research
Published January 16, 2020 Kai He, Ph.D. | Mayo Clinic PKD Foundation (PKDF): How did you first get involved in PKD research? Kai: After my Ph.D. training in molecular cell biology and biochemistry, I started my postdoctoral research at Mayo Clinic studying the...
by PKD Foundation Staff | Mar 19, 2019 | Research
There are some truly fascinating techniques in the research field being used to help increase our understanding of PKD. This week, our Chief Scientific Officer, Dr. David Baron, shares how the development of kidney organoids may help us get closer to new treatments:...
by PKD Foundation Staff | Mar 4, 2019 | Advocacy, Awareness, Education
This past week, 450 rare disease advocates and patients descended on Washington, D.C., for Rare Disease Week, and I was glad to be amongst them. It was a packed agenda with four days of activities and awareness opportunities and I’d like to share the highlights:...
by PKD Foundation Staff | Apr 24, 2018 | ADPKD, PKD Foundation News, Research
Today is a historic day in providing hope to patients with polycystic kidney disease. We are excited to announce that the U.S. Food and Drug Administration (FDA) granted approval of JYNARQUE™ (tolvaptan) to be the first treatment in the United States for adult...
